Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Michielin · SciRah

Researcher profile · Semantic Scholar

O. Michielin

Share profile

O. Michielin — researcher profile on SciRah

h-index: 77
Works: 375
Citations: 35K

Most-cited papers

Clinical relevance of tumour-associated macrophages
M. Pittet, O. Michielin, D. Migliorini
2022Nature Reviews Clinical Oncology655 citations Open access
Semantic Scholar
SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina
Marine Bugnon, U. Röhrig, Mathilde Goullieux, Marta A. S. Perez +3 more
2024Nucleic Acids Research546 citations Open access
Semantic Scholar
SwissParam 2023: A Modern Web-Based Tool for Efficient Small Molecule Parametrization
Marine Bugnon, Mathilde Goullieux, U. Röhrig, Marta A. S. Perez +3 more
2023Journal of Chemical Information and Modeling313 citations Open access
Semantic Scholar
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
A. Cortellini, G. Dettorre, U. Dafni, J. Aguilar-Company +39 more
2022Journal for ImmunoTherapy of Cancer255 citations Open access
Semantic Scholar
Dendritic cells direct circadian anti-tumour immune responses
Chen Wang, C. Barnoud, Mara Cenerenti, Mengzhu Sun +17 more
2022Nature224 citations Open access
Semantic Scholar
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy.
E. Ghisoni, A. Wicky, H. Bouchaab, M. Imbimbo +21 more
2021European Journal of Cancer188 citations Open access
Semantic Scholar
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
I. Pires da Silva, T. Ahmed, I. Reijers, A. Weppler +24 more
2021The Lancet Oncology185 citations Open access
Semantic Scholar
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumour microenvironment and cross-resistance to immunotherapy in melanoma
Lisa Haas, Anais Elewaut, C. Gerard, Christian Umkehrer +20 more
2021Nature Cancer176 citations Open access
Semantic Scholar
Myeloid Antigen-Presenting Cell Niches Sustain Antitumor T Cells and License PD-1 Blockade via CD28 Costimulation
Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, D. Barras +32 more
2021Cancer Cell169 citations Open access
Semantic Scholar
Novel targets for immune-checkpoint inhibition in cancer.
Maxime Borgeaud, J. Sandoval, M. Obeid, G. Banna +3 more
2023Cancer Treatment Reviews130 citations Open access
Semantic Scholar
The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience
M. Bragina, A. Daina, Marta A. S. Perez, O. Michielin +1 more
2022International Journal of Molecular Sciences130 citations Open access
Semantic Scholar
Turning tumors from cold to inflamed to improve immunotherapy response.
C. Gerard, J. Delyon, Alexandre Wicky, K. Homicsko +2 more
2021Cancer Treatment Reviews106 citations
Semantic Scholar
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
M. Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker, R. Bill +32 more
2021Science immunology83 citations Open access
Semantic Scholar
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment
C. Garbe, U. Keim, T. Amaral, C. Berking +23 more
2022Journal of Clinical Oncology82 citations Open access
Semantic Scholar
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
S. Boughdad, S. Latifyan, C. Fenwick, H. Bouchaab +11 more
2021Journal for ImmunoTherapy of Cancer79 citations Open access
Semantic Scholar
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
J. Schmidt, Johanna Chiffelle, Marta A. S. Perez, Morgane Magnin +28 more
2023Nature Communications69 citations Open access
Semantic Scholar
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
P. Bhave, T. Ahmed, S. Lo, A. Shoushtari +43 more
2022Journal for ImmunoTherapy of Cancer63 citations Open access
Semantic Scholar
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Anti-Tumor T-cell Immunity
Aayoung Hong, M. Piva, Si-Xue Liu, W. Hugo +21 more
2020Cancer Discovery62 citations Open access
Semantic Scholar
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
O. Michielin, A. Lalani, C. Robert, Padmanee Sharma +1 more
2022Journal for ImmunoTherapy of Cancer51 citations Open access
Semantic Scholar
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.
S. Goldinger, K. Buder-Bakhaya, S. Lo, A. Forschner +36 more
2021European Journal of Cancer51 citations Open access
Semantic Scholar
Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors.
D. Arangalage, Nils Degrauwe, O. Michielin, P. Monney +1 more
2021Cancer Treatment Reviews47 citations Open access
Semantic Scholar
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
J. Ressler, M. Karasek, L. Koch, R. Silmbrod +12 more
2021Journal for ImmunoTherapy of Cancer46 citations Open access
Semantic Scholar
Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity
Maura Garofalo, L. Piccoli, Margherita Romeo, M. M. Barzago +11 more
2021Nature Communications44 citations Open access
Semantic Scholar
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
C. Garbe, R. Dummer, T. Amaral, R. Amaria +22 more
2023Nature Medicine39 citations Open access
Semantic Scholar
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
Alexander Coukos, J. Vionnet, M. Obeid, H. Bouchaab +9 more
2022Journal for ImmunoTherapy of Cancer39 citations Open access
Semantic Scholar
Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
Z. Drobni, O. Michielin, T. Quinaglia, D. Zlotoff +10 more
2022European Journal of Cancer38 citations Open access
Semantic Scholar
Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1).
U. Röhrig, O. Michielin, V. Zoete
2021Journal of Medicinal Chemistry35 citations Open access
Semantic Scholar
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives
M. Middleton, C. Hoeller, O. Michielin, C. Robert +3 more
2020British Journal of Cancer32 citations Open access
Semantic Scholar
Neoadjuvant Immunotherapy: A Promising New Standard of Care
Emma Boydell, J. L. Sandoval, O. Michielin, M. Obeid +2 more
2023International Journal of Molecular Sciences27 citations Open access
Semantic Scholar
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response.
F. Dimitriou, A. Zaremba, C. Allayous, K. Kähler +15 more
2021European Journal of Cancer25 citations Open access
Semantic Scholar
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study.
A. M. da Silva Lopes, S. Colomer-Lahiguera, N. Mederos-Alfonso, V. Aedo-Lopez +11 more
2021European Journal of Cancer20 citations Open access
Semantic Scholar
Cystathionine‐gamma‐lyase overexpression in T cells enhances antitumor effect independently of cysteine autonomy
M. Lancien, Lucile Gueno, S. Salle, Emmanuel Mérieau +10 more
2021Cancer Science18 citations Open access
Semantic Scholar
SwissBioisostere 2021: updated structural, bioactivity and physicochemical data delivered by a reshaped web interface
Alessandro Cuozzo, A. Daina, Marta A. S. Perez, O. Michielin +1 more
2021Nucleic Acids Res.18 citations Open access
Semantic Scholar
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab
Laure Thouvenin, M. Charrier, S. Clément, Y. Christinat +8 more
2021Gynecologic Oncology Reports17 citations Open access
Semantic Scholar
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
A. M. da Silva Lopes, S. Colomer-Lahiguera, Célia Darnac, Stellio Giacomini +9 more
2023Supportive Care in Cancer16 citations Open access
Semantic Scholar
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma
Victoria Federico Paly, M. Kurt, Li-Rong Zhang, M. Butler +7 more
2022MDM Policy & Practice16 citations Open access
Semantic Scholar
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
K. Homicsko, R. Dummer, C. Hoeller, J. Wolchok +10 more
2022Cancers16 citations Open access
Semantic Scholar
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma
V. Aedo-Lopez, C. Gerard, S. Boughdad, Bianca Gautron Moura +7 more
2022Cancers16 citations Open access
Semantic Scholar
Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
I. Pires da Silva, D. Zakria, T. Ahmed, Claudia Trojanello +13 more
2022Journal for ImmunoTherapy of Cancer16 citations Open access
Semantic Scholar
Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
U. Röhrig, S. R. Majjigapu, A. Reynaud, F. Pojer +8 more
2021Journal of Medicinal Chemistry16 citations Open access
Semantic Scholar
Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapy.
A. Hepner, V. Atkinson, J. Larkin, R. Burrell +15 more
2021European Journal of Cancer16 citations
Semantic Scholar
Combining SiRPα decoy–coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cells
Evangelos K. Stefanidis, Aikaterini Semilietof, Julien Pujol, Bili Seijo +6 more
2024Journal of Clinical Investigation15 citations Open access
Semantic Scholar
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
Marie-Luise Hilbers, F. Dimitriou, Peter K. H. Lau, P. Bhave +9 more
2021European Journal of Cancer15 citations Open access
Semantic Scholar
Author Correction: Clinical relevance of tumour-associated macrophages
M. Pittet, O. Michielin, D. Migliorini
2022Nature Reviews Clinical Oncology14 citations Open access
Semantic Scholar
Structure-based prediction of BRAF mutation classes using machine-learning approaches
F. Krebs, C. Britschgi, S. Pradervand, R. Achermann +5 more
2022Scientific Reports12 citations Open access
Semantic Scholar
Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology
F. Krebs, V. Zoete, Maxence Trottet, Timothée Pouchon +2 more
2021npj Precision Oncology12 citations Open access
Semantic Scholar
Structural Prediction of Peptide-MHC Binding Modes.
Marta A. S. Perez, M. Cuendet, U. Röhrig, O. Michielin +1 more
2022Methods in molecular biology11 citations
Semantic Scholar
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer
M. Saillard, Mara Cenerenti, Patrick Reichenbach, Philippe Guillaume +21 more
2025Science Advances9 citations Open access
Semantic Scholar
Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy
Perrine Courlet, D. Abler, M. Guidi, P. Girard +15 more
2023CPT: Pharmacometrics & Systems Pharmacology9 citations Open access
Semantic Scholar
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma
F. Krebs, B. Moura, E. Missiaglia, V. Aedo-Lopez +6 more
2023International Journal of Molecular Sciences9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Zoete×12
Invite
V. Zoete — researcher profile on SciRah
C. Gerard×9
Invite
C. Gerard — researcher profile on SciRah
P. Ascierto×8
Invite
P. Ascierto — researcher profile on SciRah
G. Long×8
Invite
G. Long — researcher profile on SciRah

×7

Invite

L. Zimmer — researcher profile on SciRah

Marta A. S. Perez×6

Invite

Marta A. S. Perez — researcher profile on SciRah

Invite

A. Wicky — researcher profile on SciRah

Invite

S. Latifyan — researcher profile on SciRah

Invite

K. Homicsko — researcher profile on SciRah

Invite

M. Cuendet — researcher profile on SciRah

Invite

J. Mangana — researcher profile on SciRah

Invite

U. Röhrig — researcher profile on SciRah